Article Details

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio | BioPharma Dive

Retrieved on: 2025-09-10 04:05:31

Tags for this article:

Click the tags to see associated articles and topics

Novartis to gain heart drug in $1.4B deal for Tourmaline Bio | BioPharma Dive. View article details on hiswai:

Excerpt

Dive Brief: Novartis on Tuesday said it will pay $1.4 billion to acquire the New York-based biotechnology company Tourmaline Bio and its ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo